The global corneal implants market accounted for USD 446.0 million in 2023 and is expected to reach at USD 895.3 million by 2034 with a CAGR of 6.54% during the forecast period 2024-2034. Rising prevalence of eye conditions such as keratoconus, Fuchs dystrophy, & infectious keratitis, increase in the introduction of novel pharmaceutical products, higher individual spending power, growing awareness regarding eye donation, enhancements in eye care facilities, eye banking regulations, & cornea trade practices, surge in advancements in technological progress, rising demand for minimally invasive corneal transplantation procedures, and increasing emphasis on the development of corneal implants are some of the key factors boosting the market growth.
Increasing emphasis on the development of corneal implants is predicted to boost the market growth during the forecast period. The market for collagen-based bio-engineered artificial corneas is experiencing significant demand due to their favorable attributes, including affordability, compatibility with biological systems, and improved safety and efficacy. For instance, in May 2023, Eluminex Biosciences (Eluminex) has revealed that its clinical pivotal study (CLARITY), which is assessing a new biosynthetic corneal implant (EB-301) in progress in China, was acknowledged for its innovative contributions at two recent international ophthalmology conferences hosted in the United States.
By type, human cornea was the highest revenue-grossing segment in the global corneal implants market in 2023 owing to the improved Visual Acuity (VA) results, strong efficacy of the human cornea, and increasing alliances & cooperations among key players in the market. For instance, in September 2022, Celregen and Cellusion Inc. secured a collaborative licensing agreement for corneal endothelial cell regeneration therapy in the Greater China region. Additionally, synthetic type is predicted to grow at the fastest CAGR during the forecast period owing to the scarcity of human corneas, rising incidence of vision impairment caused by corneal opacification, and increase in pioneering research & development endeavors.
By surgery method, penetrating keratoplasty was the highest revenue-grossing segment in the global corneal implants market in 2023 owing to its safety and effectiveness, comparative benefits over newer methods like circumventing stromal interface and efficacy in addressing significant central perforations, along with growing endorsements from regulatory authorities. For instance, in January 2022, Microkpro announced that their MIOK Keratoprosthetics have been granted regulatory approval by NMPA, the Chinese regulatory body for drugs and medical devices. MIOK is the first artificial cornea ever approved globally. It eliminates the need for co-implantation of donor corneas, potentially drawing a substantial customer base to the company. Additionally, endothelial keratoplasty is predicted to grow at the fastest CAGR during the forecast period owing to the increasing occurrence of Fuchs Dystrophy. Endothelial keratoplasty represents the latest technique in corneal transplantation, replacing only the affected tissue rather than the entire thickness of the cornea. This results in quicker and more effective visual recovery while reducing the likelihood of infection and surface eye injuries.
By application, Fuchs dystrophy was the highest revenue-grossing segment in the global corneal implants market in 2023 owing to the expanding elderly demographic, rising prevalence of Fuchs dystrophy, and growing demand for treatment options including corneal implants. Additionally, keratoconus is predicted to grow at the fastest CAGR duirng the forecast period owing to the emergence of sophisticated corneal implant techniques like Deep Anterior Lamellar Keratoplasty (DALK), the presence of FDA-approved corneal implants, and a rising emphasis on the innovation of advanced products. For instance, in November 2023, According to a press release from Sechenov University, scientists have devised a functional prototype of a cornea by innovating a new collagen matrix primarily used for dental reconstruction. The objective is to use this artificial cornea as a substitute for damaged or keratoconus-affected biological corneas.
By end-user, hospitals was the highest revenue-grossing segment in the global corneal implants market in 2023 owing to the existence of proficient surgeons, increasing patient volume, availability of international eye banks, and swift integration of state-of-the-art technological devices. For instance, in January 2023, A hospital in China affiliated with Tongji Medical College at Huazhong University of Science and Technology in Wuhan has accomplished its inaugural artificial cornea transplant surgery, which was a success, performed on a 25-year-old woman. Additionally, ambulatory surgical centers (ASCs) is predicted to grow at the fastest CAGR during the forecast period owing to the procedure can be completed in a single day, leading to shorter wait times, decreased expenses, diminished infection risks, and improved nurse-to-patient ratios, and rise in funding from various public and private initiatives. Corneal implant procedures are typically conducted as outpatient treatments across various healthcare facilities.
North America region is anticipated for the highest revenue share during the forecast period owing to the participation of prominent market participants, effective reimbursement strategies, rising research & development endeavors concerning corneal implants, and expanding collaborations among industry stakeholders. For instance, in July 2022, Precise Bio and Carl Zeiss Meditec have collaborated to create and manufacture tissue-based implants for ophthalmic purposes. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the higher occurrence of ophthalmic diseases, increase in healthcare spending, and growing emphasis from market players on innovating new products. For instance, in August 2022, according to a published article, researchers from the L V Prasad Eye Institute (LVPEI), IIT Hyderabad, and the Center for Cellular and Molecular Biology in India joined forces to create a 3D-printed cornea using human corneal tissue.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Increasing emphasis on the development of corneal implants is predicted to boost the market growth during the forecast period. The market for collagen-based bio-engineered artificial corneas is experiencing significant demand due to their favorable attributes, including affordability, compatibility with biological systems, and improved safety and efficacy. For instance, in May 2023, Eluminex Biosciences (Eluminex) has revealed that its clinical pivotal study (CLARITY), which is assessing a new biosynthetic corneal implant (EB-301) in progress in China, was acknowledged for its innovative contributions at two recent international ophthalmology conferences hosted in the United States.
By type, human cornea was the highest revenue-grossing segment in the global corneal implants market in 2023 owing to the improved Visual Acuity (VA) results, strong efficacy of the human cornea, and increasing alliances & cooperations among key players in the market. For instance, in September 2022, Celregen and Cellusion Inc. secured a collaborative licensing agreement for corneal endothelial cell regeneration therapy in the Greater China region. Additionally, synthetic type is predicted to grow at the fastest CAGR during the forecast period owing to the scarcity of human corneas, rising incidence of vision impairment caused by corneal opacification, and increase in pioneering research & development endeavors.
By surgery method, penetrating keratoplasty was the highest revenue-grossing segment in the global corneal implants market in 2023 owing to its safety and effectiveness, comparative benefits over newer methods like circumventing stromal interface and efficacy in addressing significant central perforations, along with growing endorsements from regulatory authorities. For instance, in January 2022, Microkpro announced that their MIOK Keratoprosthetics have been granted regulatory approval by NMPA, the Chinese regulatory body for drugs and medical devices. MIOK is the first artificial cornea ever approved globally. It eliminates the need for co-implantation of donor corneas, potentially drawing a substantial customer base to the company. Additionally, endothelial keratoplasty is predicted to grow at the fastest CAGR during the forecast period owing to the increasing occurrence of Fuchs Dystrophy. Endothelial keratoplasty represents the latest technique in corneal transplantation, replacing only the affected tissue rather than the entire thickness of the cornea. This results in quicker and more effective visual recovery while reducing the likelihood of infection and surface eye injuries.
By application, Fuchs dystrophy was the highest revenue-grossing segment in the global corneal implants market in 2023 owing to the expanding elderly demographic, rising prevalence of Fuchs dystrophy, and growing demand for treatment options including corneal implants. Additionally, keratoconus is predicted to grow at the fastest CAGR duirng the forecast period owing to the emergence of sophisticated corneal implant techniques like Deep Anterior Lamellar Keratoplasty (DALK), the presence of FDA-approved corneal implants, and a rising emphasis on the innovation of advanced products. For instance, in November 2023, According to a press release from Sechenov University, scientists have devised a functional prototype of a cornea by innovating a new collagen matrix primarily used for dental reconstruction. The objective is to use this artificial cornea as a substitute for damaged or keratoconus-affected biological corneas.
By end-user, hospitals was the highest revenue-grossing segment in the global corneal implants market in 2023 owing to the existence of proficient surgeons, increasing patient volume, availability of international eye banks, and swift integration of state-of-the-art technological devices. For instance, in January 2023, A hospital in China affiliated with Tongji Medical College at Huazhong University of Science and Technology in Wuhan has accomplished its inaugural artificial cornea transplant surgery, which was a success, performed on a 25-year-old woman. Additionally, ambulatory surgical centers (ASCs) is predicted to grow at the fastest CAGR during the forecast period owing to the procedure can be completed in a single day, leading to shorter wait times, decreased expenses, diminished infection risks, and improved nurse-to-patient ratios, and rise in funding from various public and private initiatives. Corneal implant procedures are typically conducted as outpatient treatments across various healthcare facilities.
North America region is anticipated for the highest revenue share during the forecast period owing to the participation of prominent market participants, effective reimbursement strategies, rising research & development endeavors concerning corneal implants, and expanding collaborations among industry stakeholders. For instance, in July 2022, Precise Bio and Carl Zeiss Meditec have collaborated to create and manufacture tissue-based implants for ophthalmic purposes. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the higher occurrence of ophthalmic diseases, increase in healthcare spending, and growing emphasis from market players on innovating new products. For instance, in August 2022, according to a published article, researchers from the L V Prasad Eye Institute (LVPEI), IIT Hyderabad, and the Center for Cellular and Molecular Biology in India joined forces to create a 3D-printed cornea using human corneal tissue.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Type, Surgery Method, Application, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Corneal Implants Market Report 2023 - 2034
Corneal Implants Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Mn)
- Synthetic
- Semi-Synthetic (Collagen-Based)
- Purely Synthetic (Polymethyl Methacrylate)
- Human Cornea
Corneal Implants Market Analysis & Forecast by Surgery Method 2023 - 2034 (Revenue USD Mn)
- Endothelial Keratoplasty
- Penetrating Keratoplasty
Corneal Implants Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Mn)
- Infectious Keratitis
- Fuchs Dystrophy
- Corneal Ulcers
- Keratoconus
- Others
Corneal Implants Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Hospitals
- Ophthalmic Centers
- Ambulatory Surgical Centers
Corneal Implants Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Corneal Implants Market: Type Estimates & Trend Analysis
8. Corneal Implants Market: Surgery Method Estimates & Trend Analysis
9. Corneal Implants Market: Application Estimates & Trend Analysis
10. Corneal Implants Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Corneal Implants Market
13. Europe Global Corneal Implants Market
14. Asia Pacific Global Corneal Implants Market
15. Latin America Global Corneal Implants Market
16. MEA Global Corneal Implants Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- DIOPTEX
- Aurolab
- AJL Ophthalmic S.A.
- Presbia PLC
- Florida Lions Eye Bank
- Alcon Inc.
- KeraMed Inc.
- San Diego Eye Bank
- CorneaGen
- Massachusetts Eye and Ear
